Merck to help produce rival J&J's COVID-19 vaccine

Updated : March 02, 2021 08:59 PM IST

Drugmaker Merck & Co. will help produce rival Johnson & Johnsons newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.

The announcement comes as the White House looks to speed the production of the single-dose vaccine. Officials have said J&J faced unexpected production issues with its vaccine and produced only 3.9 million doses ahead of its receiving emergency use authorization on Saturday. The company says it is on pace to deliver 100 million doses by the end of June.

The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.

President Joe Biden is set to highlight the development in a speech Tuesday afternoon. The official confirmed Merck's involvement on condition of anonymity ahead of Biden's public announcement.

The news was first reported by The Washington Post.

Published : March 02, 2021 08:59 PM IST

Merck to help produce rival J&J's COVID-19 vaccine

You May Also Like

Coronavirus news highlights: Section 144 in Maharashtra, night curfew imposed from 8 pm to 7 am until May 1

Carnelian Capital expects further correction in market in next 1-2 months

Private vehicles to be fined Rs 1,000 for unnecessary travel

Trending on CNBC-TV18

recommended for you